搜尋結果
Search drug information, interaction, images & medical diagnosis. The most comprehensive database of medicines available in China, Hong Kong, Taiwan, Malaysia, Singapore, Philippines, Vietnam, Thailand, Indonesia and India Register for a MIMS account and ...
Advanced or unresectable HCC w/ bevacizumab 840 mg every 2 wk, or 1,200 mg every 3 wk, or 1,680 mg every 4 wk, until loss of clinical benefit or unmanageable toxicity. Tecentriq should be administered prior to bevacizumab when given on the same day. Bevacizumab is administered at 15 mg/kg every 3 wk. Click to view Tecentriq detailed prescribing ...
Herbesser 30 tab 30 mg. Packing/Price. 1000's ($1,500/pack) Form. Herbesser 60 tab 60 mg. Packing/Price. 1000's ($2,800/pack) Herbesser 30/Herbesser 60 (diltiazem): Angina pectoris, variant angina pectoris 30 mg tds, may increase to 60 mg. Essential HTN (mild to moderate) 30-60 mg.
Concise Prescribing Info. Contents. Bilastine. Indications/Uses. Symptomatic treatment of allergic rhino-conjunctivitis (seasonal & perennial) & urticaria. 20 mg tab For adult & adolescents ≥12 yr. 10 mg orodispersible tab (ODT) For childn 6-11 yr w/ body wt of at least 20 kg. Click to view Labixten detailed prescribing information.
Dosage/Direction for Use. Severe hypocitraturia Initiate w/ 60 mEq/day (30 mEq bd or 20 mEq tds). Mild to moderate hypocitraturia Initiate w/ 30 mEq/day (15 mEq bd or 10 mEq tds). Click to view Urocit-K detailed prescribing information.
Dosage/Direction for Use. Adult & childn >12 yr 2 sprays into each nostril once daily-bd. Max daily dose: 4 sprays into each nostril. Childn 4-11 yr 1 spray into each nostril once daily-bd. Max daily dose: 2 sprays into each nostril. Click to view Flixonase detailed prescribing information.
Administer as IV infusion over 60 min. Unresectable stage III NSCLC 10 mg/kg every 2 wk until disease progression, unacceptable toxicity, or max of 12 mth. ES-SCLC 1,500 mg in combination w/ chemotherapy every 3 wk (21 days) for 4 cycles, followed by 1,500 mg every 4 wk as single agent until disease progression or unacceptable toxicity. Patient ...
